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Mitogens such as bacterial lipopolysaccharides (LPS) 1 (1), the purified protein
derivative of tuberculin WPM (2), or fetal calf serum (FCS) (3) stimulate a large
part of all small, resting B-lymphocytes to proliferation and to the development
of IgM-secreting plasma cells . This mitogenic stimulation can be monitored by
an increase in thymidine uptake and by the appearance of direct plaque-forming
cells (PFC) assayed with densely coupled trinitrophenylated sheep red cells
(TNP-SRBC) (4) . The general activation of B-cells makes possible biochemical
analyses of changes that take place after stimulation. IgM synthesis and
secretion increase selectively over synthesis and secretion of other cellular
proteins. IgM synthesized at the increased rate is secreted as a 19S pentamer (5,
6) .
Mitogens may help to understand molecular processes which occur when B cells are
activated and which regulate proliferation and differentiation of B cells into plasma cells.
Knowledge of the structure of the mitogen may help to direct the search for the sites of
interaction and for the structural requirements of these interactions on B cells. Only the
structure of LPS, however, has been elucidated. Lipid A has been found to be the
mitogenic part (4) . The structures of the mitogenic principles of PPD or FCS are
unknown. We report here experiments which show that the lipoprotein of the outer
membrane of Escherichia coli is a B-cell mitogen.
The lipoprotein of the outer membrane of E. coli is a major protein of the cell wall (7) .
The sequence of the 57 amino acids has been elucidated (8, 9) . One-third ofthe lipoprotein
is covalently bound to the murein (peptidoglycan) of the cell wall (10, 11) . Two fatty acids
are bound to glycerylcysteine at the N-terminal end of the polypeptide chain (12) . An
additional fatty acid residue occupies the N-terminal a-amino group of the polypeptide
(12). The fatty acids are distinct from those present in the LPS (13) in that no a-hydroxy
myristic acid occurs in the lipoprotein (12) . The conformation of the lipoprotein is mainly
a-helical (14) . The lipoprotein aggregates in aqueous solution due to the covalently linked
lipid and due to the arrangement of all hydrophobic amino acids along one side of the
a-helix. This lipoprotein occurs in several Enterobacteriaceae (7, 15, 16) .
'Abbreviations used in this paper: Con A, concanavalin A; FCS, fetal calf serum; LPS,
lipopolysaccharide from gram-negative bacteria ; PFC, plaque-forming cells; PPD, purified protein
derivative of tuberculin; TNP, trinitrophenyl.
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Because of its well-known structure and because of the possibilities to modify
this structure specifically, by the lipoprotein may be a powerful mitogen in prob-
ing B-lymphocytes for their molecular mechanisms of activation .
Materials and Methods
Animals. C3H/HeJ mice were obtained from Jackson Laboratories, Bar Harbor, Maine. C3H/
Tif/BOM and BALB/c nu/nu-mice were obtained from G1. Bomholtgard, Ry, Denmark. All animals
were between 6 and 10 wk of age.
Cells, Media, and Reagents.
￿
Cell suspensions were prepared as described (5, 6) and cultured in
serum-free RPMI 1640-medium (Microbiological Associates, Inc., Bethesda, Md.) supplemented
with fresh glutamine (2 mM/ml), streptomycin and penicillin (100 /Ag/ml each), HEPES buffer (10
mmol), and mercaptoethanol (5 x 10-sM) at a cell density of 5 x 10' cells/ml in Falcon plastic tubes
(no. 2054; Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) in 0.5-ml aliquots per tube. Assays were
done at least in triplicate. LPS from Salmonella abortus-equi was a phenol-water preparation. PPD
was batch RT27 from Statens Serum Institut, Copenhagen, Denmark and contained 50,000 IU/mg.
Murein and Lipoprotein.
￿
Murein-lipoprotein complex was isolated as previously described (10,
17) . In short E. coli cells were disrupted with glass beads and the cytoplasm was separated from the
envelope by differential centrifugation. The cell envelope was solubilized in 4% boiling sodium
dodecyl sulfate. The large murein-lipoprotein complex (mol wt, 4 x 10') was spun down and washed
four times with water to remove the detergent and with it the last detectable traces of LPS and
phospholipids. TheLPS content of this murein-lipoprotein complexwascertainly below 1% as judged
by the content of hydroxymyristic acid of this preparation.
Muropeptide-containing lipoprotein was prepared by degradation of murein-lipoprotein complex
with lysozyme (18) . Lipoprotein was freed from the enzyme and the murein-degradation products by
chromatography on Sephadex G75 (18) . The resulting lipoprotein contains on the average three
muropeptides covalently bound .
Murein-free lipoprotein was obtained by incubation of murein-lipoprotein complex with trypsin
for 30 min at 37°C. Most of the released lipoprotein stayed with the murein due to its insolubility in
buffer solution. Liprotein was solubilized in 4% sodium dodecyl sulfate andprecipitated again by ad-
dition of an equal volume of acetone. The lipoprotein pellet was resuspended four times in 80% ace-
tone in water and thus freed from the detergent.
Isolation of Protein from Salmonella.
￿
Thepreparation represents amixture of proteins obtained
from the Salmonella minnesota R595 mutant (19) . Briefly R595 bacteria were treated with 0.05 M
EDTA in 4% NaCl, at 25°C for 30 min. They were centrifuged, the supernate dialyzed against
phosphate-buffered saline, and lyophilized. A Morgan-Elson reaction as described by Stominger et
al. (20) on 0.5 mg of the preparation hydrolysed in 6 N HCl at 100°C for 6 h showed no detectable
glucosamine. Also, in lethal toxicity tests in adrenalectomized mice (21), the mean lethal dose (LDbo)
of the preparation was found to be higher than 100 kg. The homologous R595 LPS was found to
contain 12.5% of glucosamine and its LDso was of the order of 0.01 kg.' Theabsence of glucosamine
and the low toxicity of the isolated proteins are interpreted as evidence for the absence of any
significant amounts of LPS.'
Assays for Mitogenicity.
￿
Uptake of radioactive thymidine (22), the development of direct PFC
assayed with densely coupled TNP-SRBC (4), incorporation of radioactive leucine in cell cultures,
and the serological determination of leucine-labeled IgM and its characterization by size and
polypeptide chain composition on polyacrylamide gels (5, 6) were done as described in detail
previously. Data in Tables I, II, IV, and V include standard errors of the means of triplicate determi-
nations calculated by Student's t test.
Results
Mitogenic Activity ofLipoprotein.
￿
Lipoprotein from the outer membrane of
E. coli was tested with different lymphocyte populations for its capacity to
' Galanos, C., et al . Manuscript in preparation.
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increase thymidine uptake, to induce the development of direct PFC assayed
with densely coupled TNP-SRBC, and to increase synthesis and secretion of
[3H]leucine-labeled IgM selectively over synthesis and secretion of other cellular
proteins. Two kinds of lipoprotein were tested for their capacity to stimulate
lymphocytes. Both kinds oflipoprotein differ only in the carboxyl-terminal end of
the polypeptide chain. The "muropeptides containing lipoprotein" were released
from murein by lysozyme and consists ofthe complete lipid-polypeptide chain to
which two to three muropeptides remain attached (18). The "murein-free
lipoprotein" released by trypsin consists of the lipid-polypeptide chain lacking
the carboxyl-terminal amino acid sequence tyrosyl-arginyl-lysine (9, 17). Activa-
tion of the different cell populations by two known B-cell mitogens, PPD and
LPS, and by one known T-cell mitogen, concanavalin A (Con A) (23) was also
tested . Tables I, II, and III summarize the results.
Murein-free and muropeptides-containing lipoprotein both stimulate splenic
lymphocytes from C3H/Tif and from BALB/c nu/nu mice, but not thymus cells
from C3H/Tif mice, to increased thymidine uptake Table I), to the development
of PFC (Table II), and to a selectively increased rate of IgM synthesis and
secretion (Table III). Free murein is not active in any of the assays. Con A
stimulates only thymidine uptake but no development of PFC, and does so also
in thymus cells, as expected from a T-cell mitogen. We conclude that the
lipoprotein, either in free form or with bound muropeptides is a B-cell mitogen.
The stimulation of murine B-lymphocytes by lipoprotein is dose dependent.
Free lipoprotein exhibits one rather narrow dose optimum between 1 and 10
Ag/ml, while the muropeptides-containing form shows two doseoptima around 10
ug/ml and between 50 and 100 Mg/ml (Fig. 1) . The cause for the two dose optima
for the muropeptides-containing form of lipoprotein is at present unknown.
Experiments performed with splenic lymphocytes separated according to size
by velocity sedimentation (5) (data not shown) indicate that, as with PPD and
LPS, the main lipoprotein-sensitive cells are small, resting B cells. Small spleen
cells from BALB/c nu/nu mice which lack functional T cells are equally well
activated by lipoprotein than unseparated spleen cells from C3H/Tif mice which
possess functional T cells. This indicates that the activation of B cells by
lipoprotein is T-cell independent and does not need serum factors or adherent
cells.
Mitogenic Activity of Lipid-Depleted Lipoprotein.
￿
Ester-linked fatty acids
located at the NH, terminal end of the lipoprotein can be removed by alkaline
hydrolysis (12). This leaves a lipoprotein in which only the amide-linked fatty
acid remains bound. Results in Table IV show that such a lipid-depleted
lipoprotein preparation has lost its mitogenic activity. It suggests that ester-
linked fatty acids in the lipoprotein are involved in the mitogenic action on B
cells. They may be involvedin the proper anchoringofthe lipoprotein in the lipid
bilayer of the B-lymphocyte plasma membrane .
Different Sites of Action of LPS and of Lipoprotein on Murine B
Lymphocytes. B lymphocytes from C3H/HeJ mice are low responders to
mitogenic stimulation by LPS, but high responders to stimulation by PPD (24,
25), while B lymphocytes from C3H/Tif mice are high responders to the
stimulation by both LPS and PPD. Two distinct sites of mitogenic action have476
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TABLE I
Stimulation of Thymidine Uptake* by Lipoprotein
" Cells cultured for 48 h were incubated for 1 h with 10 juCi [methyl-11]thymidine (5
Ci/mmol, The Radiochemical Centre, Amersham, England) and uptake into DNA
measured as described in reference 18.
$ 1, BALB/c nu/nu spleen; 2, C3H/Tif spleen; 3, C3H/HeJ spleen; and 4, C3H/Tif
thymus.
§ Lower doses down to 0.0025 jug/ml also did not show any mitogenic effects.
therefore been postulated for B lymphocytes (22) . Results in Tables I, II, and III
and in Fig. 1 shown that C3H/HeJ and C3H/Tif B lymphocytes are high
responders to the lipoprotein . This rules out a LPS contamination in the
lipoprotein preparations as cause for the observed mitogenic activity. It indicates
that LPS andlipoprotein from the outer membrane of gram-negative bacteria are
two mitogens which act at two distinct sites on B lymphocytes.
Mitogen Cell source$
Radioactivity
(10- ' x 3H-labeled
cpm/2.5 x 108
cultured cells)
None 1 0.2 t 0.1
2 0.2 t 0.1
3 0.2_+O.1
4 0.1 f 0.1
LPS (50 jug/ml) 1 14.0 t 0.7
2 19.6 t 1 .0
3 1.5 t 0.5
4 0.2 t0.1
PPD(50 Ag/ml) 1 6.2 t 0.4
2 8.4 t 0.7
3 6.6 t0.8
4 0.3 t0.1
Con A(5 gg/ml) 1 0.4 t 0.1
2 10.7 t 0.7
3 9.3 t 0.8
4 15.6 t 0 .9
Murein-free lipoprotein (4 gg/ml) 1 24.4 t 1.5
2 20.4 t 2 .0
3 24.8 t 2.5
4 0.5 t 0.1
Muropeptides-containing lipoprotein (10 jug/ml) 1 22.4 t 2 .5
2 26.5 t 3.5
3 23.4 t 2.0
4 0.1 t0.1
Murein§ (25 ug/ml) 1 0.5 t 0.1
2 0.4 t 0.1
3 0.4+0.1
4 0.1 t 0.1FRITZ MELCHERS, VOLKMAR BRAUN, AND CHRIS GALANOS
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TABLE II
Stimulation of B Cells to the Development of PFCAgainst TNP-SRBCt by Lipoprotein
PFC/2 .5 x 108 cultured cells
* 1 ml packed SRBC were coupled with 30 mg trinitrobenzene-sulphonic acid (Sigma Chemical Co .,
St. Louis, Mo.) and used in a direct plaque assay as described in reference 4.
tl, BALB/c nu/nu spleen; 2, C3H/Tifspleen; 3, C3H/HeJ spleen; and 4, C3H/Tif thymus .
§ Cells were exposed to rabbit antimouse IgM antibodies 2 h before mitogenic stimulation with
antibodies and under conditions described in detail in reference 23 .
11 ND, not determined.
1( Lowerdoses down to 0.025 jug/ml also did not show any mitogenic effects.
Inhibition of Lipoprotein-Mediated B-Lymphocyte Stimulation by Anti-Ig
Antibodies. Anti-Ig antibodies inhibit the LPS- and PPD-mediated mitogenic
stimulation of B lymphocytes (26) . Results in Tables II and III show that anti-Ig
antibodies added to B cells before mitogenic stimulation also inhibit the
Mitogen Cell source$ No
pretreatment
After pretreat-
ment with anti-
Ig antibodies§
None 1 25 t 10 10 t5
2 25f10 15 f5
3 35f10 15 t5
4 5 t5 ND11
LPS (50 )ug/ml) 1 850 t 100 40 t 15
2 690 +80 30 t 15
3 30 t 15 15 t 5
4 20 +10 ND
PPD(50yg/ml) 1 1,170 t 250 55 t 25
2 1,700 f 300 25 t 10
3 1,500 t 150 25 t 15
4 20f10 ND
ConA(5 gg/ml) 1 20 t 10 ND
2 20 t 10 ND
3 30110 ND
4 10 t 10 ND
Murein-free lipoprotein (4 Ag/ml) 1 1,150 t 100 25 t 10
2 1,870 t 180 45 t 20
3 1,555 t 205 30 t 15
4 20 t 10 ND
Muropeptides-containing lipoprotein (10 jig/ml) 1 2,650 t 300 50 t 20
2 3,450 f 350 55 t 15
3 2,800 t 300 25 t 10
4 25 t 10 ND
Murein 1` (25 Rg/ml) 1 45 t 10 ND
2 55 t 10 ND
3 ND ND
4 ND ND478
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TABLE III
Induction of Selectively Increased Rates of Synthesis and Secretion of Leucine-Labeled
IgM over Rates of Synthesis and Secretion of all Cellular Proteins* by Lipoprotein
Rate of IgM
*Incorporation of [4,5-'H]leucine (55 Ci/mmol, 66 jCi/ml, the Radiochemical Centre, Amersham,
England) into cells cultured for 72 hwas done for 4h under conditions described in references 5and
6. Serological determinations of radioactive protein were carried out as also described there. Se-
creted Ig from LPS-, PPD-, and lipoprotein-activated cell cultures was found to over 90% as 19S
IgM consisting of Hp - and L chains.
f In thymus cells no significant synthesis or secretion of leucine-labeled IgM could be detected.
§ 1, BALB/c nu/nu spleen; 2, C3H/Tifspleen; and 3, C3H/HeJ spleen.
~~ Pretreatment of cells with rabbit antimouse IgM antibodies wasas described in the legend to Table
II.
Mitogen Cell source$,§
Synthesis
% of total
Secretion
cellularprotein
None 1 2 3
2 3 2
3 2 4
After pretreatment with 1 1 2
anti-Ig antibodies 11 2 2 2
3 1 2
LPS (50gg/ml) 1 15 60
2 12 55
3 3 3
After pretreatment with 1 2 2
anti-Ig antibodies 2 2 2
3 2 2
PPD (50 mg/ml) 1 12 45
2 12 55
3 15 60
After pretreatment with 1 2 2
anti-Ig antibodies 2 2 3
3 3 3
Murein-free lipoprotein (4 1 10 45
Ag/ml) 2 9 55
3 8 50
After pretreatment with 1 3 2
anti-Ig antibodies 2 2 2
3 3 3
Muropeptides-containing 1 12 50
lipoprotein (10Ag/ml) 2 10 40
3 8 60
After pretreatment with 1 2 2
anti-Ig antibodies 2 2 2
3 2 3FRITZ MELCHERS, VOLKMAR BRAUN, AND CHRIS GALANOS
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Mitogenic PFCresponse of spleen cellsof C3H/Tif(O, A) andof C3H/HeJ (", A) mice with
different doses of murein-free (", O) and of muropeptides-containing (A, A) lipoprotein. 2.5 x 10'
cells were cultured in 0.5 ml medium and assayed at day 3 of stimulation with densely coupled
TNP-SRBC for direct PFC. For details see the Materials and Methods.
TABLE IV
Mitogenic Activity ofAlkali-Treated, Lipid-Depleted Lipoprotein
*Assayed against TNP-SRBC as described in thelegend to Table II with
BALB/c nu/nu spleen cells.
$Murein-free lipoprotein was dissolved in 0.33 N NaOH at 250jig/ml. One
part wasimmediately neutralized with HClandincubatedfor1hat 56*C
(control), while the other part (alkali treated) was neutralized only after
the 1 h incubation at 37°C. No loss of mitogenic activity was observed
between the immediately neutralized solution andalipoprotein solution,
which was never exposed to either NaOH, HCI, or heat.
Mitogen
None
PFC/2.5 x 10°
cultured cells*
15 f 10
LPS
50 eg/ml 1,650 f 150
Murein-free lipoprotein$
1rAg/rnl 1,260 +70
10 pg/ml 2,220 f 180
Alkali-treated murein-free lipoprotein$
1rig/ml 80 f 20
10 pg/ml 280 t 20480
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lipoprotein-mediated stimulation to the development ofPFC and to a selectively
increased IgM synthesis and secretion. It indicates that, as it was discussed
previously (23), surface membrane-bound Ig receptor molecules are part of a
functional complex of structures containing the LPS-, the PPD-, and the
lipoprotein-specific receptor sites which are involved in the regulation of
13-lymphocyte stimulation.
Mitogenic Activity in LPS-Free Protein Preparation from Salmonella.
￿
Sal-
monella contains a lipoprotein in the outer membrane which cannot be distin-
guished from that ofE. coli by amino acid analysis (15). From this close similarity
in structure one may expect that the lipoprotein from Salmonella acts as a B-cell
mitogen.
Data in Table V show that an LPS-free protein preparation from Salmonella
exhibited mitogenic activity with splenic lymphocytes from C3H/Tif and from
C3H/HeJ mice. After alkaline treatment the protein preparation lost its mito-
genic activity. Although the protein preparation containsmany differentbacterial
proteins these results may be taken as a first indication that this mitogenic ac-
tivity ofSalmonella may reside in its lipoprotein ofthe outermembrane.
Discussion
The lipid A portion of LPS and the lipoprotein both are highly conserved
structures in gram-negative bacteria . It is predictablethatlipoprotein from other
gram-negative bacteria will prove to be mitogenic for B cells. It is tempting to
speculate that the active component(s) of PPD and of FCS are lipoprotein-like
molecules. Preliminary experiments in our laboratory indicate that this may be
so: alkaline hydrolysis performed on PPD and FCS under conditions describedin
the Results (Table IV) abolishes the mitogenic activities of PPD and FCS.
Gram-negative bacteria are abundant in the bacterial flora of the gut and the
tonsils. A long symbiosis of bacteria and mammals has occurred during
evolution. This may explain why recognition structures exist on mammaliancells
such as lymphocytes for bacterial membrane structures which are different from
TABLE V
Mitogenic Activity of a Protein Preparation from Salmonella
* Cultured in serum-free medium and assayed against TNP-SRBC as described in the legend to
Table II.
fPrepared as described in the Materials and Methods.
§ Alkaline hydrolysis was performed as described in Table IV .
Mitogens
PFC/2.5 x
C3H/Tif
splenocytes
10°cultured cells*
C3H/HeJ
splenocytes
None 20 t 10 15 t 10
LPS (50gg/ml) 1,500 t 200 40 t 20
PPD(50jig/ml) 1,250 f 100 1,080f 150
Salmonella protein$ (50 jug/ml) 1,750 350 1,250t 250
Salmonella protein after alkaline hydrolysis§ 200 t 50 120 t 30
(50kg/ml)FRITZ MELCHERS, VOLKMAR BRAUN, AND CHRIS GALANOS
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antigen-binding sites of antibody molecules. It is, however, puzzling that these
bacterial membrane components, LPS and lipoprotein in Enterobacteriaceae,
induce the polyclonal proliferation and differentiation of resting B lymphocytes
into PFC. It remains unclear at present what biological function such a polyclonal
stimulation of B cells may have in ontogeny, differentiation, and regulation of
function of antigen-reactive lymphocytes .
Summary
The lipoprotein of the outer membrane of Escherichia coli is a B-cell mitogen in
mice . Polyclonal activation of B lymphocytes was measured by an increase in
thymidine uptake, by the development of plaque-forming cells against densely
coupled trinitrophenylated sheep red cells, and by selectively increased rates of
synthesis and secretion of leucine-labeled IgM. Murein-free and muropeptides-
containing lipoprotein are effective in B-cell activation, while free murein is
inactive. Removal of ester-linked fatty acids from the amino-terminal end of the
lipoprotein by alkaline hydrolysis abolishes the mitogenicity of the lipoprotein. B
lymphocytes from high responder (C3H/Tif and BALB/c nu/nu) or from low
responder (C3H/HeJ) mice to the mitogen lipopolysaccharide (LPS) both
respond well to the lipoprotein. Anti-immunoglobulin antibodies inhibit the
mitogenic stimulation of B cells by lipoprotein. A complex of structures including
the Ig-receptor molecules, the LPS receptor, and the lipoprotein receptor appear
involved in the regulation of mitogenic stimulation of B cells to proliferation and
differentiation to IgM-secreting cells .
Theable technical assistance ofMiss D. JablonskiandMiss C. Rufenachtis gratefully acknowledged.
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